PSI CRO is a global, full-service clinical research organization known for its strong track record of on-time trial delivery; a key operational differentiator, with performance exceeding 90% in 2024. We specialize in pivotal phase 2 and 3 trials across oncology, hematology, gastroenterology, autoimmune disorders, infectious diseases, neurology and more. Our expertise extends to complex precision medicine studies, including platform/umbrella designs, immunotherapy, radiopharm, and cell & gene therapy.